Cross-sectional prevalence of pancreatic cystic lesions in patients with acromegaly, a single-center experience.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 509, doi. 10.1007/s11102-017-0810-1
- By:
- Publication type:
- Article
Works matching IS 1386341X AND DT 2017 AND VI 20 AND IP 5
Results: 15
1
2
Pituitary dysfunction in granulomatosis with polyangiitis.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 594, doi. 10.1007/s11102-017-0811-0
- By:
- Publication type:
- Article
3
Impairment of osmotic challenge-induced neurohypophyseal hormones secretion in sepsis survivor rats.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 515, doi. 10.1007/s11102-017-0812-z
- By:
- Publication type:
- Article
4
Acromegaly: surgical results in 548 patients.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 522, doi. 10.1007/s11102-017-0813-y
- By:
- Publication type:
- Article
5
Contribution of sellar dura integrity to symptom manifestation in pituitary adenomas with intratumoral hemorrhage.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 531, doi. 10.1007/s11102-017-0814-x
- By:
- Publication type:
- Article
6
Visual outcomes after endoscopic endonasal pituitary adenoma resection: a systematic review and meta-analysis.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 539, doi. 10.1007/s11102-017-0815-9
- By:
- Publication type:
- Article
7
Erratum to: Acromegaly: surgical results in 548 patients.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
8
Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 553, doi. 10.1007/s11102-017-0817-7
- By:
- Publication type:
- Article
9
The extended, transnasal, transsphenoidal approach for anterior skull base meningioma: considerations in patient selection.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 561, doi. 10.1007/s11102-017-0818-6
- By:
- Publication type:
- Article
10
Association between ACE and AGT polymorphism and cardiovascular risk in acromegalic patients.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 569, doi. 10.1007/s11102-017-0819-5
- By:
- Publication type:
- Article
11
Best candidates for dopamine agonist withdrawal in patients with prolactinomas.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 578, doi. 10.1007/s11102-017-0820-z
- By:
- Publication type:
- Article
12
Late-onset X-linked adrenal hypoplasia (DAX-1, NR0B1): two new adult-onset cases from a single center.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 585, doi. 10.1007/s11102-017-0822-x
- By:
- Publication type:
- Article
13
Combined dexamethasone and desmopressin test in the differential diagnosis of ACTH-dependent Cushing's syndrome and pseudo-cushing's states.
- Published in:
- 2017
- By:
- Publication type:
- Letter
14
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 489, doi. 10.1007/s11102-017-0838-2
- By:
- Publication type:
- Article
15
Genetic analysis of IRF6, a gene involved in craniofacial midline formation, in relation to pituitary and facial morphology of patients with idiopathic growth hormone deficiency.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 499, doi. 10.1007/s11102-017-0808-8
- By:
- Publication type:
- Article